Boston Scientific (BSX) Long-Term Deferred Tax (2009 - 2026)

Boston Scientific has disclosed Long-Term Deferred Tax across 18 years of filings, most recently posting $4.0 billion for Q1 2026.

• Long-Term Deferred Tax for Q1 2026 came in at $4.0 billion, up 7.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.0 billion (up 7.54% YoY), and the FY2025 annual result was $3.7 billion, up 0.55% from the prior year.
• Long-Term Deferred Tax came in at $4.0 billion for Q1 2026 at Boston Scientific, up from $3.7 billion in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $4.1 billion in Q1 2022 to a low of $3.7 billion in Q4 2024.
• The 5-year median for Long-Term Deferred Tax is $3.8 billion (2023), against an average of $3.8 billion.
• Across the five-year window, Long-Term Deferred Tax slipped 4.92% in 2023 and advanced 7.54% in 2026, its largest moves.
• Boston Scientific's Long-Term Deferred Tax stood at $3.9 billion in 2022, then retreated by 2.56% to $3.8 billion in 2023, then retreated by 4.84% to $3.7 billion in 2024, then rose by 0.55% to $3.7 billion in 2025, then grew by 7.56% to $4.0 billion in 2026.
• The last three Long-Term Deferred Tax figures came in at $4.0 billion (Q1 2026), $3.7 billion (Q4 2025), and $3.7 billion (Q3 2025), per Business Quant data.